Finance entity
All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention Ben Bradford, the most common co-covered peer. Kendalle Burlin O'Connell appears in 1 tracked Finance story from August 25, 2026. The tracked stories average 2 original sources each.
Last mentioned: 1h ago
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: markets. Of the tracked stories, 1 of 1 also mention Ben Bradford, the most common co-covered peer. Kendalle Burlin O'Connell appears in 1 tracked Finance story from August 25, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 8 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Kendalle Burlin O'Connell. Shared-story counts are live from our verified record — not editorial picks.
Investors see a bifurcated biotech recovery: hot IPOs and $79 billion in China-discovered licensing deals mask shrinking seed-stage venture funding. MassBio's 2026 report highlights how venture capital is concentrating in later-stage, less risky assets.
Source: biopharmadive.com · BioPharma Dive
Kendalle Burlin O'Connell is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
